Back

Telo Genomics says TELO-MRD detects multiple myeloma cells more sensitively

Verifying
  • Telo Genomics announced clinical research on its blood-based TELO-MRD test.
  • TELO-MRD detected residual multiple myeloma cells more sensitively than traditional bone marrow tests.
  • Adaptive clonoSEQ was among the traditional bone marrow tests used for comparison.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.